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Abstract 
Objective: Diabetes mellitus (DM) is associated to the morphological and componential characteristics of atheroma‑
tous plaques. It has proven that plaque textures are related to plaque components and beneficial for atherosclerotic 
risk stratification. The aim of this study is to compare plaque textures in patients with and without DM, and examine 
the relationship between HbA1c levels and the ultrasound plaque textures in atherosclerotic patients.
Methods: A total of 136 participants (among them 66 are diabetic and 70 are non‑diabetic) suffering from carotid 
plaques were included. About 300 texture features were extracted from the ultrasound images of plaques using the 
algorithms of histogram, absolute gradient, run‑length matrix, gray‑level co‑occurrence matrix, autoregressive model 
and wavelet transform, respectively. Thirty optimal features were selected by the Fisher coefficient and the mutual 
information measure. The most discriminating feature (MDF) was obtained from the linear discriminant analysis for 
the optimal features. Linear regression model was performed to investigate the relationship between HbA1c and 
MDF. The receiver operating characteristics (ROC) curve was further developed to validate the relation between the 
estimated HbA1c (models output) and diabetes status.
Results: A total of 12 texture features showed statistical difference between patients with and without DM. The MDF 
was significant higher in non‑diabetic patients (0.326 ± 0.049) than diabetic patients (−0.346 ± 0.052) (p < 0.001). The 
optimal regression model (r = 0.348, p < 0.001) for HbA1c included a constant (p < 0.001) and the MDF (p < 0.001). 
The areas under ROC curve used to estimate HbA1c was 0.828.
Conclusions: The results indicate that there is a quantitative relationship between the HbA1c levels and plaque tex‑
tures in ultrasonic images of atherosclerotic patients, which may suggest that texture analysis of the ultrasonic image 
of plaque is a promising method for evaluating the cardiovascular risk caused by DM in patients with plaques.
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Background
Diabetes mellitus (DM) enable to accelerate atheroscle-
rosis and increase the risk of cardiovascular diseases [1, 
2]. Carotid intima-media thickening (IMT) measured by 
ultrasound imaging and carotid artery elasticity evalu-
ated by ultrasound radio frequency technology have been 
utilized for assessing the impact of DM on the plaques 
[3, 4]. These schemes, however, ignore some essential 
information about the plaque surface and morphology. 
Substantial evidences have indicated that quantitative 
textural analysis of the medical images can provide more 
useful diagnostic information [5], and is useful for ath-
erosclerotic risk stratification [6]. Thus, it is significant 
to characterize carotid plaques using textures in patients 
with and without DM, which may help to evaluate the 
risk of cardiovascular events caused by DM.
DM are associated with the morphological and the 
componential characteristics of carotid plaques [3, 7]. 
In previous studies, Wilhjelm et  al. [8] found that tex-
ture features of the ultrasound plaques was correlated 
with the histologically determined relative volume of soft 
materials. Niu et  al. [9] indicated that texture features 
extracted from ultrasound images of the carotid arterial 
wall were useful in identifying arterial surface roughness. 
Rakebrandt et al. [10] reported that there are five texture 
classes match with the plaque contents including fibrin, 
elastin, calcium, haemorrhage and lipid. The above stud-
ies may imply that some plaque textures are different in 
patients with and without DM. Furthermore, HbA1c is a 
risk factor for cardiovascular diseases in type 2 diabetes 
[11], and is related to the mortality in heart failure patients 
with diabetes [12]. However, few studies have investigated 
the relationship between HbA1c and plaque textures.
The aim of this study is to compare plaque textures in 
patients with and without DM, and examine the relation-




A total of 136 subjects (among them 66 are diabetic and 
70 are non-diabetic) suffering from carotid plaques were 
investigated in present study. From October 2011 to Feb-
ruary 2015, the patients received carotid artery examina-
tion at the department of ultrasound, the third affiliated 
hospital of Sun Yat-sen University. All participants pro-
vided the written informed consent. The study protocol 
was approved by the Institutional Review Board of the 
third affiliated hospital of Sun Yat-sen University (Guang-
zhou, China).
In this study, the diagnostic criteria for diabe-
tes are defined as fasting plasma glucose (FPG) level 
of  ≥7.0  mmol/L, and/or 2-h plasma glucose value 
of  ≥11.1  mmol/L, and/or HbA1c level of  ≥6.5  %, and/
or treatment with either hypoglycemic agents or insulin 
[13, 14]. Patients with acute or chronic infectious dis-
ease, alcohol or drug abuse, retinopathy, or uncontrolled 
hypertension were excluded. Information regarding age, 
gender, total number of plaques, systolic blood pressure 
(SBP), diastolic blood pressure (DBP), body mass index 
(BMI), total cholesterol, triglyceride, low density lipo-
protein cholesterol, high density lipoprotein cholesterol, 
lipoprotein, apolipoprotein A1, apolipoprotein B100, 
FPG, HbA1c and medication use were collected.
Carotid ultrasonography
The study was performed by a specialized physician 
with 5  years vascular ultrasound working experience 
using a Toshiba AplioXG SSA-790A ultrasound Plat-
form equipped with a 5–12 MHz linear-array transducer 
(PLT-805AT) and Esaote MyLab90 ultrasound Platform 
equipped with a 4–13  MHz linear-array transducer 
(LA523). The carotid artery was examined with the head 
tilted slightly upward in the mid-line position. The trans-
ducer was manipulated so that the near and far walls 
were parallel to the transducer footprint, and the lumen 
diameter was maximized in the longitudinal plane.
To improve the comparability of the plaque images 
obtained by different ultrasound systems at different 
settings, all images were standardized according to the 
scheme proposed by Sabetai et  al. [15] before texture 
analysis. Furthermore, it is more clinically significant 
to focus on echolucent plaques, since these plaques are 
more potentially unstable than echo-rich plaques [16]. 
Gray-scale median (GSM)  analysis is an objective and 
reproducible method for evaluating the echogenicity of 
carotid plaque [15]. In case there were multiple plaques 
in one individual, the plaques with the lowest GSM value 
among them was selected as the representative for the 
following texture analysis [17]. Two operators performed 
the GSM measurement independently, and the interop-
erator reproducibility was evaluated with a kappa value. 
The disagreement of the two operators were discussed 
and re-evaluated, then an agreement was finally achieved.
Many studies have shown that carotid intima-media 
thickening (IMT) is a high risk factor of the future cardi-
ovascular events [18–20]. Maximum IMT (Plaque-IMT-
max) was defined as the greatest axial thickness among 
the plaques in the carotid arteries [21, 22], and was meas-
ured in this study.
Texture analysis
MaZda is an effective tool for texture analysis and offers 
an approach for texture feature extraction, selection and 
reduction [23]. In MaZda, we can draw regions of interest 
with arbitrary shapes, as shown in Fig. 1. It provides six 
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various algorithms, such as histogram, absolute gradient, 
run-length matrix, co-occurrence matrix, autoregressive 
model and wavelet for features extraction [5, 23]. In pre-
sent study, about 300 texture features of carotid plaques 
were extracted using MaZda, as shown in Table 1.
Texture feature selection and reduction
In order to select optimal features among the large num-
ber of texture features of the plaques from diabetic and 
non-diabetic patients, the methods based on Fisher coef-
ficient and mutual information measure were used to 
select 15 optimal features, respectively. Furthermore, 
linear discriminant analysis (LDA) was implemented for 
the combined feature set, and the most discriminating 
features (MDF) were obtained.
Fisher coefficient
Fisher coefficient is defined as a ratio of between-class 


















where ui, vi and Pi denote the mean, the variance and 
the priori probability of class i, respectively. Texture fea-
tures with larger Fisher coefficient are selected as optimal 
features.
Mutual information measure
Mutual information (MI), a measure of dependence 
between two random variables, is defined as [25]:
where X and Y are random variables, H is the entropy. In 
case of X stores values of texture features and Y stores the 
classification decision. Then, a large MI between X and Y 
means that X is a useful texture features for classification. 
Then the MI for each texture features fi is calculated by 
[25, 26]:
where d = c1, c2, . . . , cNC means the class category, Nc is 
the total number of class, Nb is the number of histogram 























Fig. 1 The region of interest selection. a The region of interest selection according to (b) using MaZda software. b Plaque defined by a specialized 
physician with 5 years vascular ultrasound working experience
Table 1 Texture features
Histogram (1) mean, (2) variance, (3) skewness, (4) kurtosis and (5) percentiles 1, 10, 50, 90 and 99 %
Absolute gradient (1) mean, (2) variance, (3) skewness, (4) kurtosis and (5) percentage of pixels with nonzero gradient
Run-length matrix (1) run‑length nonuniformity, (2) grey‑level nonuniformity, (3) long‑run emphasis, (4) short run emphasis and (5) fraction of image in 
runs. Parameters computed for horizontal, 45° vertical and 135° orientation
Co-occurrence matrix (1) angular second moment, (2) contrast, (3) correlation, (4)sum of squares, (5) inverse difference moment, (6) sum average, (7) sum 
variance, (8) sum entropy, (9) entropy, (10) difference variance and (11) difference entropy. Parameters are computed for 4 orientations: (a, 0), (0, a), (a, 
a), (a, −a) and 5 distances: a = 1, 2, 3, 4, 5; between image pixels
Autoregressive model (1) model parameter vector includes 4 parameters and (2) standard deviation of the driving noise
Wavelet (1) Energy of wavelet coefficients in low‑frequency subbands, (2) horizontal high‑frequency subbands, (3) vertical high‑frequency subbands 
and (4) diagonal high‑frequency subbands at successive scales
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bins used for feature discretization, f di  denotes discre-
tized value of fi.
Linear discriminant analysis
LDA is a useful method for feature reduction [24]. The 
aim of LDA is to find a transform matrix W such that 




 is maximized. Where 
SB and SW  are the between-class scatter matrix and the 
within-class scatter matrix. These matrices can be given 
as formulas (4, 5).
where X(k)i  denotes the i-th pattern in class k 
(i = 1, 2, . . . ,Mk), k = 1, 2, . . . ,Nc, u(k) is the mean vec-
tor of class k. It has proved that such a transform matrix 
Φ is composed of eigenvectors corresponding to largest 
eigenvalues of S−1W SB. The MDF can be obtained when 
the original data is transformed by the means of matrix Φ 
as formula (6).
Statistical analysis
All statistical analysis was performed with PASW Sta-
tistics 18 and p less than 0.05 was considered statisti-
cally significant. All values were presented as the mean 
value ±SD, or real number of patients with the percent-
age in parentheses. Independent sample t test was used 
to examine the baseline clinical parameters between the 
diabetic and non-diabetic patients. Pearson correlation 
analysis was conducted to investigate the relationship 
between HbA1c and the variables including age, BMI, 
total number of plaques, SBP, DBP, plaque-IMTmax and 
MDF. Linear regression analysis was carried out by con-
sidering the HbA1c as a dependent variable and regard-
ing the MDF as independent variable. The optimized 
regression model was obtained to estimate the HbA1c. 
Further, the receiver operating characteristics (ROC) 
curve was developed to test the relationship between 
the estimated HbA1c (models output) and diabetes 
status.
Results
Baseline characteristics of study participants
Table 2 describes the baseline characteristics of the study 
population (n  =  136), which includes 66 patients with 
DM (age, mean ± SD, 67.8 ± 10.0 years) and 70 patients 
































(6)MDFi = ΦT (xi − u)
BMI (23.9 ± 3.1 vs 22.0 ± 2.8 kg/m2, p = 0.001), triglyc-
eride (1.90  ±  1.57 vs 1.31  ±  0.89, p  =  0.009  mmol/L), 
HbA1c (8.87 ± 2.25 vs 5.50 ± 0.41 %, p < 0.001) and FPG 
(10.76 ± 4.26 vs 5.14 ± 0.70 mmol/L, p < 0.001) were sig-
nificantly different in patients with and without DM. In 
the DM group, the ratio of patients using oral hypogly-
cemic agent, insulin, both oral hypoglycemic agent and 
insulin, and no drug for treatment were 50  % (n =  33), 
21.2 % (n = 14), 9.1 % (n = 6), and 19.7 % (n = 13).
Plaques selection
There was a good agreement between the two operators 
in selecting the plaque with the lowest GSM value in 
one individual with multiple plaques. The interoperator 
reproducibility was 97.79  % (kappa value =  0.965), and 
the 3 controversial plaques were discussed and re-evalu-
ated, then eventually an agreement was achieved.
Texture selection and reduction
A total 30 optimal features were selected based on the 
Fisher coefficient and the mutual information meas-
ure. Among the optimal features, 12 features (7 feature 
extracted by run-length matrix and 5 features extracted 
by wavelet) were considered to be statistically different 
in patients with and without DM, as shown in Table  3. 
In order to reduce the number of the optimal features, 
LDA was further performed to gain the MDF. The MDF 
(−0.035 ± 0.052 vs 0.033 ± 0.050, p < 0.001) showed sig-
nificant difference in the diabetic and the non-diabetic 
patients.
Pearson correlation of the study variables with HbA1c
Pearson correlation analysis was implemented to exam-
ine the relationship between HbA1c and the variables 
including age, BMI, total number of plaques, SBP, DBP 
and MDF. Table  4 indicates that the HbA1c is positively 
correlated with BMI (r  =  0.182, p  =  0.034), whereas 
HbA1c is negatively correlated with the MDF (r = −0.348, 
p < 0.001).
Linear regression model for HbA1c
Table  5 shows that the optimal model for HbA1c 
(r = 0.348, p < 0.001) is achieved by stepwise regression 
method. The model included a constant (p < 0.001) and 
the MDF (p < 0.001). The optimized regression equation 
can be described as formula (7) to estimate the HbA1c.
where x1 is the MDF.
Further, the ROC curve was developed to validate the 
relationship between the estimated HbA1c and diabe-
tes status, and the area under the ROC curve was 0.828 
(Fig. 2).
(7)EstimatedHbA1c = −13.297 ∗ x1 + 7.136
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Table 2 Baseline characteristics of 136 subjects
Data are presented as the mean value ±SD or percentage of subjects
CHD coronary heart disease, SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, HDL-cholesterol high density lipoprotein cholesterol, LDL-
cholesterol low density lipoprotein cholesterol, FPG fasting plasma glucose
Characteristics Diabetes (n = 66) Non-diabetes (n = 70) t p
Age, mean (SD) 67.8 ± 10.0 69.4 ± 9.8 −0.972 0.333
Male gender, n (%) 43 (65) 46 (66) 0.068 0.946
Total number of plaques 2.1 ± 1.2 2.0 ± 1.1 0.533 0.104
Hypertension, n (%) 43 (65) 44 (63) 0.277 0.783
CHD, n (%) 18 (27.3) 22 (31.4) −0.528 0.598
SBP (mm Hg) 136.9 ± 19.0 139.1 ± 22.0 −0.642 0.522
DBP (mm Hg) 75.8 ± 9.2 76.7 ± 12.8 0.465 0.643
BMI (kg/m2) 23.9 ± 3.1 22.0 ± 2.8 3.437 0.001
Total cholesterol (mmol/L) 4.78 ± 1.20 4.46 ± 1.17 −1.548 0.116
Triglyceride (mmol/L) 1.90 ± 1.57 1.31 ± 0.89 2.677 0.009
HDL‑cholesterol (mmol/L) 1.05 ± 0.28 1.13 ± 0.34 −1.484 0.140
LDL‑cholesterol (mmol/L) 3.04 ± 0.97 2.86 ± 1.06 1.023 0.308
Lipoprotein A (mg/L) 211.9 ± 219.2 284.9 ± 288.7 −1.652 0.101
Apolipoprotein A1(g/L) 1.29 ± 0.31 1.31 ± 0.26 −0.362 0.718
Apolipoprotein B100 (g/L) 1.20 ± 0.47 1.17 ± 1.23 0.163 0.871
HbA1c (%) 8.87 ± 2.25 5.50 ± 0.41 11.940 <0.001
FPG (mmol/L) 10.76 ± 4.26 5.14 ± 0.70 10.611 <0.001
Plaque‑IMTmax (mm) 2.4 ± 0.8 2.5 ± 0.8 −0.635 0.527
Table 3 Statistically different features between diabetic and non-diabetic plaques
WavEnLH_s-3 and WavEnLH_s-4 are energy of wavelet coefficients in vertical high-frequency subbands at scale 3 and 4; WavEnLL_s-1, WavEnLL_s-2 and WavEnLH_s-3 
are energy of wavelet coefficients in low-frequency subbands at scale 1, 2 and 3; 45dgr_Fraction, Vertl_Fraction and 135dr_Fraction are fraction of image in runs 
computed for 45°, vertical and 135° orientation; Vertl_ShrtREmp, Horzl_ShrtREmp, 45dgr_ShrtREmp, Vertl_ShrtREmp and 135dr_ShrtREmp are short run emphasis 
computed for horizontal, 45° vertical and 135° orientation
MDF most discriminating feature, MI mutual information
Features Non-diabetes (n = 70) Diabetes (n = 66) Fisher MI t p
WavEnLH_s‑4 756.21 ± 418.35 522.48 ± 385.45 0.342 0.109 3.383 0.001
Vertl_Fraction 0.883 ± 0.056 0.847 ± 0.096 0.213 0.036 2.630 0.010
135dr_ShrtREmp 0.921 ± 0.037 0.893 ± 0.0716 0.25 0.066 2.866 0.005
Vertl_ShrtREmp 0.915 ± 0.040 0.886 ± 0.072 0.243 0.046 2.810 0.006
WavEnLL_s‑2 16,327 ± 4554 13,092 ± 7191 0.229 0.055 2.2733 0.007
WavEnLL_s‑1 16,327 ± 4559 13,474 ± 7337 0.224 0.041 2.705 0.008
WavEnLH_s‑3 465.39 ± 275.86 343.30 ± 247.33 0.220 0.039 2.712 0.008
135dr_Fraction 0.892 ± 0.052 0.858 ± 0.091 0.213 0.040 2.627 0.010
45dgr_ShrtREmp 0.918 ± 0.038 0.892 ± 0.073 0.210 0.038 2.606 0.011
WavEnLL_s‑3 15,479 ± 4811 12,802 ± 7299 0.193 0.069 2.510 0.014
Horzl_ShrtREmp 0.816 ± 0.095 0.757 ± 0.169 0.191 0.048 2.491 0.014
45dgr_Fraction 0.887 ± 0.053 0.854 ± 0.095 0.184 0.040 2.444 0.016
MDF 0.033 ± 0.050 −0.035 ± 0.052 – – 7.712 <0.001
Table 4 Pearson correlation of the study variables with HbA1c
BMI body mass index, TNP total number of plaques, SBP systolic blood pressure, DBP diastolic blood pressure, MDF most discriminating feature
Age (year) BMI (kg/m2) TNP SBP (mmHg) DPB (mmHg) Plaque-IMTmax (mm) MDF
HbA1c (%) Pearson −0.123 0.182 −0.022 −0.071 0.084 −0.097 −0.348
p 0.155 0.034 0.795 0.408 0.333 0.262 <0.001
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Discussion
In this study, a total of 12 texture features showed sig-
nificant difference in diabetic and non-diabetic patients. 
Previous studies indicated that MD impacted the vascu-
lar structure and function [27, 28], increased the IMT of 
common carotid artery [3], and modified the relation-
ships between carotid plaque calcium, composition and 
inflammation [7]. The textural differences may be a can-
didate parameter reflecting the morphological and com-
ponential differences of the carotid plaques in patients 
with and without DM. The texture features including the 
fraction of image in runs computed for 45°, vertical and 
135° orientation, and the short run emphasis computed 
for horizontal, 45°, vertical and 135° orientation were 
statistically higher in non-diabetic patients than dia-
betic patients. The fraction of image in runs is a meas-
urement of the percentage of image pixels that are part 
of any of the runs considered for the matrix computing 
and it should have a low value for images with linear 
structure [5, 29]. Moreover, the short run emphasis, a 
feature emphasizing the short runs, is a measure of the 
proportion of short runs occurring in the image [5, 29]. 
Given the above, it may suggest that diabetes tend to 
impact plaques with a linear structure in the surface.
In previous studies, Virmani et  al. [30] indicated that 
the BMI was significantly higher in diabetic patients 
(30.5  ±  7.41  kg/m2) than in non-diabetic patients 
(26.6 ± 5.4 kg/m2) (p = 0.001). Nozue et al. [31] showed 
that BMI was significantly different in the partici-
pants with MD or not (25.3 ±  3.9 vs 23.8 ±  2.7  kg/m2, 
p  =  0.01). Marso et  al. [32] indicated that the median 
triglycerides in acute coronary syndrome patients with 
MD was 144  mg/dL, whereas that in patients without 
MD was 101 mg/dL (p < 0.001). In the study of Lee et al. 
[33] reported that the median triglycerides in subjects 
with HbA1c ranged from 3.6 to 5.2, from 5.3 to 5.4, from 
5.6 to 5.7, and from 5.8 to 6.4 were 109.1, 116.1, 120.2, 
and 127.9  mg/dL, respectively (p  <  0.001). These find-
ings are consistent with our results, in which the BMI 
(23.9 ± 3.1 vs 22.0 ± 2.8 kg/m2, p = 0.001) and triglyc-
erides (1.90 ±  1.57 vs 1.31 ±  0.89  mmol/L, p =  0.009) 
are statistically different in the patients with and without 
DM.
Ultrasound IMT measurements were considered as a 
strong predictor of future cardiovascular events [18–20]. 
Recent studies suggested that the increased IMT was not 
an independent predictor of plaque development [34, 
35]. Compare with carotid IMT, carotid plaque predicts 
cardiovascular events more accurately [36, 37]. In this 
study, the carotid plaque-IMTmax showed no statistical 
difference in patients with and without DM (2.4  ±  0.8 
vs 2.5 ± 0.8 mm, p = 0.527), whereas the MDF was sig-
nificant higher in diabetic patients (0.033 ± 0.050) than 
in non-diabetic patients (−0.035 ± 0.052) (p < 0.001). It 
may suggest that the MDF is more effective than carotid 
plaque-IMTmax in illustrating the difference of plaques 
in patients with and without DM. Additionally, MDF 
make it possible to evaluate the stability of the plaque. 
Compared with the conventional features (i.e. plaque-
IMTmax) that are evaluated visually, the MDF is an 
abstract feature that extracted from texture features 
without visual evaluation.
HbA1c testing reflects the average plasma glucose over 
the previous 2–3  months [38]. Mukai et  al. [39] indi-
cated that the crude average of the maximum carotid 
Table 5 Linear regression model of HbA1c with the coefficients of the variables involved
MDF most discriminating feature
Model Variables/constant Coefficients P 95.0 % confidence interval
Lower bound Upper bound
HbA1c (r = 0.392, p < 0.001) Constant 7.136 <0.001 6.766 7.506
MDF −13.297 <0.001 −19.407 −7.186
Fig. 2 The receiver operating characteristics curve for validating 
the relationship between estimated HbA1c and diabetes status. AUC 
represents areas under receiver operating characteristics curve
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intima-media thickness increased significantly with rising 
quartiles of HbA1c. Daida et al. [40] examined the associa-
tion between HbA1c and plaque regression, and suggested 
that plaque regression was less pronounced in patients 
with high HbA1c levels compare with those with low lev-
els. In present study, we found a relationship between 
the HbA1c levels and plaque textures in atherosclerotic 
patients, which may be useful for evaluating the impact of 
long-term blood glucose level on the carotid plaques. Fur-
thermore, Eeg-Olofsson et  al. [11] indicated that higher 
HbA1c levels increased the risks of cardiovascular disease, 
coronary heart disease and total mortality. Ikeda et  al. 
[41] showed that HbA1c was an independent risk factor 
for cardiovascular disease. The relationship between the 
MDFs and HbA1c may suggest that the MDFs can be used 
to assess cardiovascular risk, which may elevate the value 
of B-mode ultrasonography examination.
The main limitation was that this method could be 
applied only to patients with carotid plaques. The ather-
omatous plaque, however, was a common complication 
of diabetes and had a high prevalence in population [42, 
43]. Besides, the number of subjects was relatively small 
in this study. A longitudinal, prospective study utilizing 
carotid ultrasound evaluation in a large number of dia-
betic patients with plaques is required to assess the pre-
cise prognostic value of plaque textures in determining 
future cardiovascular events caused by DM.
Conclusion
In conclusion, the results of present study indicated that 
the textures of the carotid plaques were statistically dif-
ferent in patients with and without DM. The relation-
ship between the HbA1c levels and plaque textures may 
suggest that texture analysis of the ultrasound images of 
carotid plaques is a promising method to evaluate the 
risk of cardiovascular events caused by DM in patients 
with plaques.
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